Kerusso Capital Management LLC Has $3.10 Million Stock Position in The Clorox Company (NYSE:CLX)

Kerusso Capital Management LLC grew its holdings in The Clorox Company (NYSE:CLX) by 6.4% during the 3rd quarter, Holdings Channel reports. The firm owned 19,011 shares of the company’s stock after purchasing an additional 1,148 shares during the period. Clorox makes up approximately 2.0% of Kerusso Capital Management LLC’s portfolio, making the stock its 21st biggest position. Kerusso Capital Management LLC’s holdings in Clorox were worth $3,097,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Van ECK Associates Corp grew its position in shares of Clorox by 1,715.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares during the period. Nuance Investments LLC boosted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Wulff Hansen & CO. increased its position in shares of Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after buying an additional 436,891 shares in the last quarter. International Assets Investment Management LLC raised its stake in Clorox by 424.9% during the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after buying an additional 435,971 shares during the period. Finally, Boston Trust Walden Corp raised its position in shares of Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after purchasing an additional 268,966 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Up 1.5 %

Shares of CLX stock traded up $2.39 on Friday, hitting $165.16. 1,276,258 shares of the company’s stock traded hands, compared to its average volume of 1,244,660. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a market capitalization of $20.44 billion, a price-to-earnings ratio of 57.55, a P/E/G ratio of 3.02 and a beta of 0.41. The company’s fifty day simple moving average is $162.14 and its 200 day simple moving average is $146.83. The Clorox Company has a one year low of $127.60 and a one year high of $169.09.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 earnings per share. Equities analysts forecast that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is 170.03%.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.57% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on CLX. JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a report on Wednesday. Citigroup lifted their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.